tomatine has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YL; Huang, WC; Liou, CJ; Shen, SC; Wu, SJ; Yeh, KW; Yu, MC | 1 |
1 other study(ies) available for tomatine and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Tomatidine ameliorates obesity-induced nonalcoholic fatty liver disease in mice.
Topics: Animals; Anti-Inflammatory Agents; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Tomatine | 2021 |